Log in | Register

E-mail
Company Name

Melissa Herkt Joins Emerson Process Management As President

Loading...
Herkt brings extensive industry experience and strong leadership qualities to new corporate position
Emerson Process Management, an Emerson business, has announced the appointment of Melissa B. Herkt as president of Process Systems and Solutions - Americas. Herkt will lead the division created by Emerson to provide process improvement solutions to the life sciences, power, chemical, food and beverage, pulp and paper, and hydrocarbon and energy industries.

"Melissa has spent her entire career planning and delivering major projects in both the petrochemical and pharmaceutical industries," says Tom Snead, president, Systems and Solutions. "Her experience and leadership qualities are key to meeting the goals set for the Process Systems and Solutions division."

Herkt has been actively involved in global project management throughout her professional career. She has worked in the United States, the United Kingdom, France, Switzerland, Denmark, Norway, and Colombia and has conducted training in project management best practices at 66 locations in 21 countries. Her experience includes managing grassroots projects as large as $600 million and working on projects up to $3 billion in size.

Most recently Herkt was vice president of global project management for GlaxoSmithKline, where she was responsible for capital management, resource management, project manager training and development, project controls, project management standards, and the delivery performance of projects. She had previously worked for Hoffmann-La Roche, Exxon R&E, and Alabama Power Company.

Herkt holds a Bachelor of Science degree in civil engineering from Auburn University. She received the university's Civil Engineering Outstanding Alumna Award in 2004. Herkt is a member of the Board of Advisors for the Construction Industry Institute (CII) and co-chairs the CII Research Committee. She recently received the CII Outstanding Implementer Award for 2004. She serves on the Advisory Board of the University of Pittsburgh Mascaro Sustainability Initiative and is a member of the International Society of Pharmaceutical Engineers (ISPE).

Blogs

The Importance of Fundamentals

The Importance of Fundamentals

Aug 31 | Girish Malhotra, PE, President, EPCOT International

Globally, Johnson & Johnson is known for its integrity and product quality. A few years ago they handled the Tylenol situation extremely well and were commended for it. It is astounding that the year 2010 has become a nightmare for them.  

The Quality Control Unit: Invertebrates Need Not Apply

The Quality Control Unit: Invertebrates Need Not Apply

Aug 30 | The QA Pharm

The Quality Control Unit (QCU) is the only pharmaceutical function that has a job description codified in the CGMP regulations. Don’t you find this remarkable? In fact, an entire section is devoted to describing the responsibility of the QCU and how it is to operate within the organization—namely independently.        

Multimedia

Timothy Cote - Office of Orphan Products Development

Aug 13 | Root

From approving medicines to treating snake bites to Cystic Fibrosis - Dr. Tim Cote describes a special office at the FDA, designed to address needs of people with rare diseases. Timothy Cote, M.D. - Director, Office of Orphan Products Development

Charles River Labs On WuXi PharmaTech Acquisition

Charles River Labs On WuXi PharmaTech Acquisition

May 25 | Video

Charles Rivers Laboratories International Chief Officer talks about the recent WuXi PharmaTech acquisition

Biogen Idec - 2010 Facility of the Year Award Winner - Operational Excellence

Biogen Idec - 2010 Facility of the Year Award Winner - Operational Excellence

Apr 27 | Video

Peter Flinn, Biogen Idec's Senior Director, Global Project Engineering talks to Pharmaceutical Processing's Editor-In-Chief Mike Auerbach about the company's Large-Scale Manufacturing Technology Map Project in Research Triangle Park, North Carolina. The project won the 2010 Operational...

MannKind Corporation - 2010 Facility of the Year Award Winner - Equipment & Process Innovation

MannKind Corporation - 2010 Facility of the Year Award Winner - Equipment & Process Innovation

Apr 28 | Video

Juergen Martens, Ph,D. MannKind Corporation's Corporate Vice President and Chief Technical Officer talks to Pharmaceutical Processing's Editor-In-Chief Mike Auerbach durng INTERPHEX2010 about the company's Technosphere Insulin Manufacturing Facility located in Danbury, Connecticut. The...